Skip to main content

Philadelphia cell therapy startup raises $75M, names former Biogen exec as CEO

The company's founders include the Penn researcher whose work led to the development of Spark Therapeutics flagship product.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.